Narnatumab (MST1R/CD136) - Research Grade Biosimilar
Product Specifications
Background
Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors) .
Immunogen
Homo sapiens / MST1R/CD136 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-467
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
IMC RON-8, RON8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1382527-01 0.02 mg (E-Coli)
Recombinant Shigella boydii serotype 4 Chorismate synthase (aroC)
Ask
View Details MBS1382527-02 0.02 mg (Yeast)
Recombinant Shigella boydii serotype 4 Chorismate synthase (aroC)
Ask
View Details MBS1382527-03 0.1 mg (E-Coli)
Recombinant Shigella boydii serotype 4 Chorismate synthase (aroC)
Ask
View Details